These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 26631176)

  • 1. Tamoxifen and Antidepressant Drug Interaction in a Cohort of 16,887 Breast Cancer Survivors.
    Haque R; Shi J; Schottinger JE; Ahmed SA; Cheetham TC; Chung J; Avila C; Kleinman K; Habel LA; Fletcher SW; Kwan ML
    J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26631176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of antidepressants and breast cancer recurrence.
    Baker H
    Lancet Oncol; 2016 Jan; 17(1):e11. PubMed ID: 26687592
    [No Abstract]   [Full Text] [Related]  

  • 3. Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study.
    Kelly CM; Juurlink DN; Gomes T; Duong-Hua M; Pritchard KI; Austin PC; Paszat LF
    BMJ; 2010 Feb; 340():c693. PubMed ID: 20142325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer recurrence in relation to antidepressant use.
    Chubak J; Bowles EJ; Yu O; Buist DS; Fujii M; Boudreau DM
    Cancer Causes Control; 2016 Jan; 27(1):125-36. PubMed ID: 26518198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer recurrence risk related to concurrent use of SSRI antidepressants and tamoxifen.
    Lash TL; Cronin-Fenton D; Ahern TP; Rosenberg CL; Lunetta KL; Silliman RA; Hamilton-Dutoit S; Garne JP; Ewertz M; Sørensen HT; Pedersen L
    Acta Oncol; 2010 Apr; 49(3):305-12. PubMed ID: 20156115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physicians' assessments of adjuvant tamoxifen's effectiveness in older patients with primary breast cancer.
    Lash TL; Gurwitz JH; Silliman RA
    J Am Geriatr Soc; 2005 Nov; 53(11):1889-96. PubMed ID: 16274369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Patient safety with breast cancer and depression: Concomitant use of paroxetine and tamoxifen].
    Muquebil Ali Al Shaban Rodríguez OW; Pérez Castro P; Estrada Alarcón N; Tuñón Gorgojo L
    J Healthc Qual Res; 2019; 34(2):110-111. PubMed ID: 30686622
    [No Abstract]   [Full Text] [Related]  

  • 8. Effectiveness of bisphosphonate use and risk of contralateral breast cancer and recurrence in women with early-stage breast cancer treated with tamoxifen.
    Kwan ML; Shi JM; Habel LA; Song J; Chung JW; Avila CC; Schottinger JE; Cheetham TC; Fletcher SW; Haque R
    Breast Cancer Res Treat; 2016 Apr; 156(2):379-89. PubMed ID: 27002508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen's protection against breast cancer recurrence is not reduced by concurrent use of the SSRI citalopram.
    Lash TL; Pedersen L; Cronin-Fenton D; Ahern TP; Rosenberg CL; Lunetta KL; Silliman RA; Hamilton-Dutoit S; Garne JP; Ewertz M; Sørensen HT
    Br J Cancer; 2008 Aug; 99(4):616-21. PubMed ID: 18665165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology study.
    Guha N; Kwan ML; Quesenberry CP; Weltzien EK; Castillo AL; Caan BJ
    Breast Cancer Res Treat; 2009 Nov; 118(2):395-405. PubMed ID: 19221874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of concomitant CYP2D6 inhibitor use and tamoxifen adherence on breast cancer recurrence in early-stage breast cancer.
    Dezentjé VO; van Blijderveen NJ; Gelderblom H; Putter H; van Herk-Sukel MP; Casparie MK; Egberts AC; Nortier JW; Guchelaar HJ
    J Clin Oncol; 2010 May; 28(14):2423-9. PubMed ID: 20385997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in co-prescribing of antidepressants and tamoxifen among women with breast cancer, 2004-2010.
    Dusetzina SB; Alexander GC; Freedman RA; Huskamp HA; Keating NL
    Breast Cancer Res Treat; 2013 Jan; 137(1):285-96. PubMed ID: 23149465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
    Lancet; 1998 May; 351(9114):1451-67. PubMed ID: 9605801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five-year patterns of adjuvant hormonal therapy use, persistence, and adherence among insured women with early-stage breast cancer.
    Nekhlyudov L; Li L; Ross-Degnan D; Wagner AK
    Breast Cancer Res Treat; 2011 Nov; 130(2):681-9. PubMed ID: 21842245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK.
    Bromley SE; Matthews A; Smeeth L; Stanway S; Bhaskaran K
    J Cancer Surviv; 2019 Aug; 13(4):632-640. PubMed ID: 31321612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term use of tamoxifen reduces the risk of dementia: a nationwide population-based cohort study.
    Sun LM; Chen HJ; Liang JA; Kao CH
    QJM; 2016 Feb; 109(2):103-9. PubMed ID: 25852154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial.
    Powles TJ; Ashley S; Tidy A; Smith IE; Dowsett M
    J Natl Cancer Inst; 2007 Feb; 99(4):283-90. PubMed ID: 17312305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
    Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
    J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamoxifen use reduces the risk of osteoporotic fractures in women with breast cancer in Asia: a nationwide population-based cohort study.
    Tzeng HE; Muo CH; Chen HT; Hwang WL; Hsu HC; Tsai CH
    BMC Musculoskelet Disord; 2015 May; 16():123. PubMed ID: 25989902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smaller reduction in 3D breast density associated with subsequent cancer recurrence in patients with breast cancer receiving adjuvant tamoxifen therapy.
    Kim JY; Cho N; Jeyanth JX; Kim WH; Lee SH; Gweon HM; Moon WK
    AJR Am J Roentgenol; 2014 Apr; 202(4):912-21. PubMed ID: 24660724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.